1301700-82-2

Basic information

• Product Name: 1-chloroethyl carbamate cinacalcet
• Synonyms: 1-chloroethyl carbamate cinacalcet
• CAS NO: 1301700-82-2
• Molecular Weight: 463.927
• Mol File: 1301700-82-2.mol

Chemical Properties

• CAS DataBase Reference: 1-chloroethyl carbamate cinacalcet(CAS DataBase Reference)
• NIST Chemistry Reference: 1-chloroethyl carbamate cinacalcet(1301700-82-2)
• EPA Substance Registry System: 1-chloroethyl carbamate cinacalcet(1301700-82-2)

Safety Data

• Hazardous Substances Data: 1301700-82-2(Hazardous Substances Data)

Upstream product

• 364782-34-3 cinacalcet hydrochloride 
• 226256-56-0 cinacalcet 
• 50893-53-3 carbonochloridic acid 1-chloro-ethyl ester 
• 1206633-38-6 (R)-N-methyl-N-(1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine 

Downstream Products

• 226256-56-0 cinacalcet 

Relevant articles and documents

Oligomer and related compd. [...] -

The invention relates to (among other things) oligomer-calcimimetic conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered compounds.

A PROCESS FOR THE PREPARATION OF CINACALCET AND ITS SALTS

A process for preparing (cinacalcet) α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-l- naphthalenemethanamine (formula I): or a pharmaceutically acceptable salt thereof which comprises: a) reacting 1-acetonaphthone with an alkyl amine or a substituted or non-substituted aralkyl amine in presence of a suitable solvent to form imine compound (formula III), which on reduction using suitable reducing agent yields N-substituted naphthyl ethyl amine (formula IV). b) Optionally resolving the N-substituted naphthyl ethyl amine (formula (IV) into its corresponding (R) or (S) isomer (formula IVa and IVb). c) Further reacting the (R,S) or (R) or (S)-N-substituted naphthyl ethyl amine (formula IV, IVa, or IVb) with trifluoromethyl aryl alkyl compound (formula V) in presence of a base and in a suitable solvent to form an intermediate corresponding to (R5S), (R) or (S)-N-substituted- methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-l-naphthalenemethanamine (N-substituted- cinacalcet) (formula VI, Via or VIb). d) Optionally resolving (R,S)-N-substituted cinacalcet (formula VI) into its corresponding (R) and (S) isomers (formula Via or VIb). e) Converting (R5S) or (R) or (S)-N-substituted-cinacalcet (formula VI, Via or VIb) to the corresponding (R5S) or (R) or (S)-α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-l- naphthalenemethanamine (cinacalcet) (formula, I5 Ia or Ib)) by dealkylation or debenzylation, f) Optionally resolving (R,S)-α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-l- naphthalenemethanamine (cincacalcet, formula I) into (R) and (S)-α-methyl-N-[3-[3- (trifluoromethyl)phenyl]propyl]-l-naphthalenemethanamine (formula Ia and Ib) using a suitable resolving agent.